OMED played the Jeffries conference well. Announce a CELG partnership and then phase 3 testing protocol and an upgrade. That would be a nice dble whamo for GERN to follow.
This board is beginning to look like TSRX's bfr the buyout. No posters looks like no interest and no buyers. Low vol. price take down.
that was such a blatant joke. Twice within that 3 month time frame as the stock moved up lightening round featured a call on TSRX and his response BOTH times where "I don't know about that company, I'll have to get back to you on that one." The SP gained several $'s after each wait. What a memory lapse. The show is totally rigged. A friend waited several days to place a "random call" in. They bumped his call with some other news flash into the second day. Never got his 5 minutes of fame.
same thing happened to DRTX when some lawsuit with another drug company and Cubist was cited as a potential threat in the future...it had nothing to do with DRTX. These analysts are picking up from CNBC and Cramer in blatant misperceptions in order to manipulate price movements.
Have you been watching OMED's deal with CELG? They announced their phase 3 protocol today...up another 12%
pretty pathetic when this whole investment mind set has become so sinister. But then again maybe they've just downgraded thinking you would think they're buying cheaper but they intend to short a perfectly good stock to force you to lose whilst they cover. The market reacts slow to some of these catalysts as a result of short covering when vol can't force a squeeze. Hope it picks up later this morning
they were badly beaten down earlier this fall when GSK released CCXI from their previous vercirnon alliance deal. No one thought the rest of the pipeline had much promise if GSK wasn't interested. Neither CCX-354(phase II proof of concept) nor CCX-168 had been tested further under the previous GSK deal and until recently phase II on 168 is showed promising results. $15 target if all goes well. Just goes to show you sometimes partnering up with the big guys isn't a means of getting stuff done faster. CCX-140 plus 4 other drugs are in various stages of testing phases. A lot going on for a $5-$6 stock. May chase some in the morning.
sounds good "ChemoCentryx (CCXI), up 10.3% after announcing positive top-line data from two steps of a Phase II trial for the company's blood vessel inflammation treatment" should see a nice run tomorrow. Thanx for the heads up. Yahoo was really screwed up today.
a red herring if ever I smelt one.
Feb 2012; Hospira, Inc. advised of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of CUBICIN® (daptomycin for injection). CBST countered by a patent infringement suit forcing a 30-month stay of approval imposed by the FDA on Hospira's ANDA. How this related to DRTX is anyone's guess.
Aria worth a look if ur into FDA conspiracy theories. They got the okay in Euro but the FDA nixed it here. May become the next DNDN. Price has been slowly recovering.
both TKMR and CGIX had nice breakouts since Kobi mentioned them on the board earlier last week. They're in a similar DNA RNA based treatment space.
...their pipeline is cutting edge with DNA RNA based compounds that trigger/control immune responses in the treatment of B-cell lymphoma and other autoimmune diseases. Chart has recently broken out of a bullish wedge indicating a significant bullish move upwards. One of many companies presenting updated pipeline data at the upcoming 25th Annual Piper Jaffray Healthcare Conference next week. ACAD and GERN are also presenting. Holding both.
as many that have dropped out many more are successfully being treated. Look at the potential upside in helpful treatment....did you play Zoom today?
Abe Lincoln, Winston Churchill. Jimmy Hendrix, Robert Downey Jr, Jim Carey, Robin Williams, Mel Gibson, Marilyn Monroe, Russel Brand, Catherine Zeta-Jones, Charlie Sheen to name a few. With treatment these disorders can lead to a whole fulfilled life.